Akorn, Inc. (NASDAQ: AKRX), a leading specialty generic pharmaceutical company, announced that its shareholders, at ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE